Biomarkers of diabetes

A molecular biomarker is a gene, molecule, or natural trait that helps recognize disease. In diabetes, HbA1c is considered a biomarker to identify risk factors for retinopathy, vascular disease and nephropathy. These provide preventative measures during the subclinical phase. The proper use of the biomarker in the growth of anti-diabetic drugs can help in a quick and better understanding of the pathological process of diabetes.


    Related Conference of Biomarkers of diabetes

    October 16-17, 2023

    4th Asia Pacific Congress on Diabetes and Endocrinology

    Vancouver, Canada
    October 16-17, 2023

    2nd World congress and Expo on Diabetes

    Vancouver, Canada
    October 21-22, 2023

    4th World Summit on Diabetes Expo

    New York, USA
    November 13-14, 2023

    3rd European Endocrinology and Diabetes Congress

    Paris, France
    November 16-17, 2023

    7th Annual Conference on Diabetes and Endocrinology

    Paris, France
    November 20-21, 2023

    17th European Diabetes and Endocrinology Congress

    Dubai, UAE
    November 22-23, 2023

    19th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2023

    27th International Conference on Diabetes, Endocrinology and Healthcare

    Singapore City, Singapore
    January 11-12, 2024

    5th Global summit on Diabetes and Endocrinology

    Dubai, UAE
    February 08-09, 2024

    33rd European Diabetes Congress

    Paris, France
    March 25-26, 2024

    5th Annual Conference on Diabetes

    London, UK

    Biomarkers of diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in